INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 116 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2017. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $212,000 | +78.2% | 60,513 | +411.1% | 0.00% | +100.0% |
| Q3 2018 | $119,000 | +85.9% | 11,839 | +12.5% | 0.00% | 0.0% |
| Q1 2018 | $64,000 | -55.2% | 10,521 | -34.7% | 0.00% | -66.7% |
| Q3 2017 | $143,000 | -47.2% | 16,119 | -45.2% | 0.00% | -72.7% |
| Q4 2016 | $271,000 | +6.7% | 29,433 | +50.2% | 0.01% | -31.2% |
| Q2 2016 | $254,000 | -29.6% | 19,600 | +55.6% | 0.02% | -60.0% |
| Q4 2015 | $361,000 | +76.1% | 12,600 | +159.3% | 0.04% | -79.8% |
| Q4 2014 | $205,000 | – | 4,859 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVANTAGE INVESTMENT MANAGEMENT, LLC | 105 | $0 | 0.00% |
| Sterling Investment Advisors, Ltd. | 250 | $0 | 0.00% |
| Front Row Advisors LLC | 60 | $0 | 0.00% |
| Executive Wealth Management, LLC | 20 | $0 | 0.00% |
| BARCLAYS PLC | 1,300 | $0 | 0.00% |
| BARCLAYS PLC | 33,172 | $10,000 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Financial Gravity Asset Management, Inc. | 50 | $0 | 0.00% |
| Vectors Research Management, LLC | 505 | $0 | 0.00% |